SENT ON BEHALF OF DR. HOWARD FELDMAN, EXECUTIVE ASSOCIATE DEAN, RESEARCH
CIHR has recently announced their SPOR Networks in Chronic Disease funding opportunity. The key points around dates, objectives, eligibility, and funding are highlighted below.
Please stay tuned for more information to come from the VP Research & International Office regarding the coordination of applications from UBC.
Registration Deadline: December 2, 2014 (required)
*updated* LOI Deadline: January 13, 2015
*new* LOI Signatures Deadline: January 23, 2015
Full Application Deadline: October 15, 2015
Canadian Institutes of Health Research as a partner in the Strategy for Patient-Oriented Research (SPOR) has recently launched the SPOR Networks in Chronic Disease funding opportunity. SPOR Networks are national, multi-institutional, multi-disciplinary and collaborative and are comprised of collaborations of patients, health professionals, decision makers, health researchers and other stakeholders. These networks are expected to develop important and effective relationships with the other core elements of SPOR and where appropriate, with other SPOR Networks. This funding opportunity will provide support for the development and implementation of SPOR Networks in non-communicable Chronic Diseases. For the purpose of this opportunity, non-communicable chronic disease is defined as a long-term disease that is not passed from one person to another; it evolves over time, often progressing in severity. Although a non-communicable chronic disease may be prevented and can often be controlled, it is rarely cured.
Networks must focus on first-in-human and beyond research in non-communicable chronic diseases that have resulted in areas of high disease burden. Networks are strongly encouraged to explore the opportunities for impact across multiple non-communicable chronic diseases. No more than one network will be funded in any particular focus area. Although this opportunity is intended to create networks that are national in scope, successful networks are expected to include relevant international collaborations and clearly describe the added value of these collaborations.
The primary objective of the opportunity will be to translate existing and new knowledge generated by basic biomedical, clinical, and population health research into testing of innovations that can improve clinical science and practice and foster policy changes, leading to transformative and measureable improvements in patient health outcomes, and in efficiency and effectiveness of healthcare delivery within five years.
Network applicants will be expected to show that the planned program of research and knowledge translation will have a significant impact on non-communicable chronic diseases and their co-morbidities by:
- Addressing patient-oriented research priorities and developing an interdisciplinary nation-wide agenda of outcomes-oriented research.
- Accelerating the translation of existing and new knowledge generated by basic biomedical, clinical, and population health research into clinical science and practice and policy applications.
- Strengthening the capacity to conduct patient-oriented research through an integrated multidisciplinary program that provides unique and innovative training and mentoring opportunities.
- Fostering the development and implementation of evidence-informed and gender-responsive practices, policies, services, products and programs to improve patient outcomes, access to care and quality, efficiency and effectiveness of health care.
1) The Nominated Principal Applicant must be one of the following:
- An independent researcher affiliated with a CIHR eligible institution.
- A knowledge user affiliated with a CIHR eligible institution.
2) Each network must include distinct representatives from each of the following stakeholder groups (i.e., one individual representing one group or discipline – a minimum of six individuals, including the Nominated Principal Applicant):
- Researchers (minimum of three and each from a different discipline)
- Health care professionals
- Patients/family representatives/informal care providers
- Health policy makers
3) The network must demonstrate that it will be pan-Canadian in scope, i.e., that it includes Principal Applicants (key members), from a minimum of one province or territory in three of the following four regions:
- East – includes Newfoundland and Labrador, Nova Scotia, Prince Edward Island and New Brunswick
- Central – includes Quebec, Ontario and Manitoba
- West – includes Saskatchewan, Alberta and British Columbia
- North – includes Nunavut, Northwest Territories and Yukon
Total funding available from CIHR for this initiative is $50.8M:
- Letter of Intent development grants: $1.0M will be available to fund up to 20 Development Grants through the Letter of Intent stage of this opportunity. Each Development Grant will have a maximum value of $50,000. Partner funds are NOT required at this stage.
- Full applications: $49.8M will be available to fund up to four distinct networks. Each successful network will receive up to $12,450,000 over five years from CIHR and must be matched at a minimum of 1:1 with funding from non-federal sources. Partner funds ARE required at the full application stage. At this full application stage, matching partner contributions from non-federal sources can include up to 25% eligible cash equivalent contributions. Partner contributions cannot be funds that have previously been leveraged for other CIHR initiatives.
For full details on this funding opportunity, please visit the website: https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=2155&view=currentOpps&org=CIHR&type=EXACT&resultCount=25&sort=program&all=1&masterList=true
Howard Feldman MD FRCP (C)
Executive Associate Dean, Research
Professor, Division of Neurology
Faculty of Medicine, University of British Columbia